Submissions for variant NM_001369.3(DNAH5):c.1198G>A (p.Val400Met)

gnomAD frequency: 0.00050  dbSNP: rs144575803

Total submissions: 9

Submitter	RCV	SCV	Clinical significance	Condition	Last evaluated	Review status	Method	Comment
Labcorp Genetics (formerly Invitae), Labcorp	RCV000206891	SCV000259777	likely benign	Primary ciliary dyskinesia	2024-01-30	criteria provided, single submitter	clinical testing
Counsyl	RCV000667189	SCV000791605	uncertain significance	Primary ciliary dyskinesia 3	2017-05-18	criteria provided, single submitter	clinical testing
Illumina Laboratory Services, Illumina	RCV000667189	SCV001312403	uncertain significance	Primary ciliary dyskinesia 3	2018-01-12	criteria provided, single submitter	clinical testing	This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.
Genome-Nilou Lab	RCV000667189	SCV001716351	uncertain significance	Primary ciliary dyskinesia 3	2021-05-18	criteria provided, single submitter	clinical testing
Ambry Genetics	RCV000206891	SCV002645208	likely benign	Primary ciliary dyskinesia	2019-03-02	criteria provided, single submitter	clinical testing	This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center	RCV000667189	SCV004807573	uncertain significance	Primary ciliary dyskinesia 3	2024-03-29	criteria provided, single submitter	clinical testing
Biochemical Molecular Genetic Laboratory, King Abdulaziz Medical City	RCV000667189	SCV001132799	uncertain significance	Primary ciliary dyskinesia 3	2019-01-29	no assertion criteria provided	clinical testing
Natera, Inc.	RCV000206891	SCV001462746	benign	Primary ciliary dyskinesia	2019-12-06	no assertion criteria provided	clinical testing
PreventionGenetics, part of Exact Sciences	RCV003955226	SCV004771501	likely benign	DNAH5-related disorder	2021-02-09	no assertion criteria provided	clinical testing	This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).